WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 5.7787

Change

+0.00 (+0.01)%

Market Cap

N/A

Volume

150.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.45 (-1.01%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+4.40 (+0.93%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.02 (+0.89%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.27 (+0.85%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.26 (+0.52%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+6.00 (+1.49%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.32 (+0.75%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+0.44 (+0.91%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.05 (-0.77%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.35 (+0.46%)

USD 5.38B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.44% 24% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.44% 24% F 28% F
Trailing 12 Months  
Capital Gain -5.21% 13% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.21% 13% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.77% 13% F 33% F
Dividend Return -0.77% 17% F 33% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.93% 87% B+ 95% A
Risk Adjusted Return -12.98% 15% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.